Back to News
Market Impact: 0.45

GRAIL Partners With Epic to Broaden Galleri Test Access Across US

GRAL
Healthcare & BiotechTechnology & InnovationProduct LaunchesCompany Fundamentals

GRAIL partnered with Epic to embed its Galleri multi-cancer early-detection test into Epic EHRs across nearly 450 health systems, expanding digital access and streamlining clinical workflows nationwide. The integration should reduce friction for clinician ordering and results delivery, likely accelerating test adoption and associated revenue potential for GRAIL. Monitor actual uptake rates, reimbursement progress, and implementation timelines as next catalysts.

Analysis

GRAIL partnered with Epic to embed its Galleri multi-cancer early-detection test into Epic EHRs across nearly 450 health systems, expanding digital access and streamlining clinical workflows nationwide. The integration should reduce friction for clinician ordering and results delivery, likely accelerating test adoption and associated revenue potential for GRAIL. Monitor actual uptake rates, reimbursement progress, and implementation timelines as next catalysts.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.60

Ticker Sentiment

GRAL0.60